{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:24:16Z","timestamp":1776734656702,"version":"3.51.2"},"reference-count":53,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1,31]]},"abstract":"<jats:p>Background: Hypertension is prevalent in chronic kidney disease (CKD). Studies suggest that reduction in dietary salt intake reduces blood pressure (BP). We studied relationships between salt intake, BP and renin\u2013angiotensin system regulation in order to establish if it is disordered in CKD.<\/jats:p>\n               <jats:p>Methods: Mechanistic crossover study of CKD patients versus non-CKD controls. Participants underwent modified saline suppression test prior to randomization to either low or high salt diet for 5 days and then crossed over to the alternate diet. Angiotensin-II stimulation testing was performed in both salt states. BP, urea and electrolytes, and plasma aldosterone concentration (PAC) were measured.<\/jats:p>\n               <jats:p>Results: Twenty-seven subjects were recruited (12 CKD, 15 control). There was no difference in age and baseline BP between the groups. Following administration of intravenous saline, systolic BP increased in CKD but not controls (131 \u00b1 16 to 139 \u00b1 14 mmHg, P=0.016 vs 125 \u00b1 20 to 128 \u00b1 22 mmHg, P=0.38). Median PAC reduced from 184 (124,340) to 95 (80,167) pmol in controls (P=0.003), but failed to suppress in CKD (230 (137,334) to 222 (147,326) pmol (P=0.17)). Following dietary salt modification, there was no change in BP in either group. Median PAC was lower following high salt compared with low salt diet in CKD and controls. There was a comparable increase in systolic BP in response to angiotensin-II in both groups.<\/jats:p>\n               <jats:p>Discussion: We demonstrate dysregulation of aldosterone in CKD in response to salt loading with intravenous saline, but not to dietary salt modification.<\/jats:p>","DOI":"10.1042\/cs20171603","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T01:40:40Z","timestamp":1515634840000},"page":"285-294","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease"],"prefix":"10.1042","volume":"132","author":[{"given":"Alison\u00a0H.M.","family":"Taylor","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair\u00a0J.","family":"Rankin","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, U.K."},{"name":"Queen Elizabeth University Hospital, Glasgow, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily\u00a0P.","family":"McQuarrie","sequence":"additional","affiliation":[{"name":"Queen Elizabeth University Hospital, Glasgow, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.\u00a0Marie","family":"Freel","sequence":"additional","affiliation":[{"name":"Queen Elizabeth University Hospital, Glasgow, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie\u00a0Z.M.","family":"Homer","sequence":"additional","affiliation":[{"name":"Queen\u2019s Medical Research Institute, University of Edinburgh, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Andrew","sequence":"additional","affiliation":[{"name":"Queen\u2019s Medical Research Institute, University of Edinburgh, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan\u00a0G.","family":"Jardine","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, U.K."},{"name":"Queen Elizabeth University Hospital, Glasgow, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick\u00a0B.","family":"Mark","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, U.K."},{"name":"Queen Elizabeth University Hospital, Glasgow, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"2021113011011583100_B1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2021113011011583100_B2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare Population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B3","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"2021113011011583100_B4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N. Engl. J. Med. Massachusetts Med. Soc."},{"key":"2021113011011583100_B5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2021113011011583100_B6","first-page":"1857","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"Remuzzi","year":"1996","journal-title":"Lancet"},{"key":"2021113011011583100_B7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1470320309352353","article-title":"Disordered aldosterone-volume relationship in end-stage kidney disease","volume":"10","author":"Bomback","year":"2009","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"2021113011011583100_B8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrneph.2015.114","article-title":"Management of hypertension in chronic kidney disease","volume":"11","author":"Townsend","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"2021113011011583100_B9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","article-title":"Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study","volume":"5","author":"Freel","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"2021113011011583100_B10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000441262","article-title":"Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety","volume":"41","author":"Bomback","year":"2016","journal-title":"Blood Purif."},{"key":"2021113011011583100_B11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrneph.2009.228","article-title":"Aldosterone \u201cescape\u201d vs \u201cbreakthrough\u201d","volume":"6","author":"Schrier","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"2021113011011583100_B12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"2021113011011583100_B13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2021113011011583100_B14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12882-016-0337-0","article-title":"Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis","volume":"17","author":"Currie","year":"2016","journal-title":"BMC Nephrol."},{"key":"2021113011011583100_B15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2009.03.066","article-title":"Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease. A Randomized Controlled Trial","volume":"54","author":"Edwards","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011011583100_B16","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int."},{"key":"2021113011011583100_B17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2215\/CJN.04750908","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"Br. Med. J."},{"key":"2021113011011583100_B19","first-page":"337","article-title":"KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"2","author":"National Kidney Foundation","year":"2012","journal-title":"Kidney Int."},{"key":"2021113011011583100_B20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2215\/CJN.01120216","article-title":"A randomized crossover trial of dietary sodium restriction in stage 3\u20134 CKD","volume":"12","author":"Saran","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B21","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1681\/ASN.2013030285","article-title":"A randomized trial of dietary sodium restriction in CKD","volume":"24","author":"McMahon","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B22","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1001\/jama.2016.4447","article-title":"Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease","volume":"315","author":"Mills","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"2021113011011583100_B23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Heerspink","year":"2012","journal-title":"Kidney Int."},{"key":"2021113011011583100_B24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced Dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane Review)","volume":"24","author":"Taylor","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"2021113011011583100_B25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2014.59","article-title":"Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease","volume":"86","author":"Fan","year":"2014","journal-title":"Kidney Int."},{"key":"2021113011011583100_B26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc10-1722","article-title":"The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes","volume":"34","author":"Thomas","year":"2011","journal-title":"Diabetes Care"},{"key":"2021113011011583100_B27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell Cardiol."},{"key":"2021113011011583100_B28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2021113011011583100_B29","first-page":"177","article-title":"Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle","volume":"22","author":"Titze","year":"2009","journal-title":"J. Nephrol."},{"key":"2021113011011583100_B30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1681\/ASN.V72306","article-title":"Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease","volume":"7","author":"Cianciaruso","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/HYPERTENSIONAHA.113.03093","article-title":"Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease","volume":"64","author":"McQuarrie","year":"2014","journal-title":"Hypertension"},{"key":"2021113011011583100_B32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMoa1311889","article-title":"Urinary sodium and potassium excretion, mortality, and cardiovascular events","volume":"371","author":"O'Donnell","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2021113011011583100_B33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0140-6736(16)30467-6","article-title":"Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies","volume":"388","author":"Mente","year":"2016","journal-title":"Lancet Elsevier"},{"key":"2021113011011583100_B34","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/ndt\/gft007","article-title":"Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease","volume":"28","author":"McQuarrie","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011011583100_B35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/CS20120015","article-title":"Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease","volume":"123","author":"McQuarrie","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011011583100_B36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1530\/JOE-14-0561","article-title":"Plasma steroid profiling and response to trophins to illustrate intra-adrenal dynamics","volume":"224","author":"McManus","year":"2015","journal-title":"J. Endocrinol."},{"key":"2021113011011583100_B37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrneph.2014.88","article-title":"Chronic kidney disease: should sodium intake be restricted in patients with CKD?","volume":"10","author":"Burnier","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"2021113011011583100_B38","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/jama.2011.574","article-title":"Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion","volume":"305","author":"Stolarz-Skrzypek","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"2021113011011583100_B39","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur. Heart J."},{"key":"2021113011011583100_B40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jacc.2013.09.057","article-title":"Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis","volume":"63","author":"Pitt","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011011583100_B41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","article-title":"Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C\u2013dependent buffering mechanism","volume":"15","author":"Machnik","year":"2009","journal-title":"Nat. Med."},{"key":"2021113011011583100_B42","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/00005344-198906148-00004","article-title":"Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview","volume":"14","author":"Missale","year":"1989","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113011011583100_B43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ndt\/16.suppl_1.53","article-title":"Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension","volume":"16","author":"Pestana","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011011583100_B44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Siragy","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"2021113011011583100_B45","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"2021113011011583100_B46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B47","doi-asserted-by":"publisher","first-page":"d4366","DOI":"10.1136\/bmj.d4366","article-title":"Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial","volume":"343","author":"Slagman","year":"2011","journal-title":"Br. Med. J."},{"key":"2021113011011583100_B48","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1681\/ASN.2004060505","article-title":"Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents","volume":"16","author":"Esnault","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011011583100_B49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1440-1681.1987.tb00382.x","article-title":"Effect of sodium depletion on pressor responsiveness in ACTH-induced hypertension in man","volume":"14","author":"Connell","year":"1987","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113011011583100_B50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00004872-198801000-00004","article-title":"Haemodynamic, hormonal and renal effects of adrenocorticotrophic hormone in sodium-restricted man","volume":"6","author":"Connell","year":"1988","journal-title":"J. Hypertens."},{"key":"2021113011011583100_B51","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011011583100_B52","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1172\/JCI88530","article-title":"Increased salt consumption induces body water conservation and decreases fluid intake","volume":"127","author":"Rakova","year":"2017","journal-title":"J. Clin. Invest."},{"key":"2021113011011583100_B53","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1161\/HYPERTENSIONAHA.115.05851","article-title":"Agreement between 24-hour salt ingestion and sodium excretion in a controlled environmentnovelty and significance","volume":"66","author":"Lerchl","year":"2015","journal-title":"Hypertension"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/2\/285\/829001\/cs-2017-1603.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/2\/285\/829001\/cs-2017-1603.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:55:03Z","timestamp":1638273303000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/132\/2\/285\/72063\/Non-uniform-relationship-between-salt-status-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,31]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20171603","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]}}}